Atlas Trials

An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)

Clinical trial NCT01697488 · COMPLETED

Trial details

NCT number
NCT01697488
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Study type
OBSERVATIONAL
Peritoneal Neoplasms
Start date
2012-02-02
Primary completion
2019-09-27
Enrollment
1090

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.